Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah E Church

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Immunity|October 22, 2015
Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a GlimpseSarah E Church, Jérôme Galon
Advances in Experimental Medicine and Biology|December 25, 2017
Regulation of CTL Infiltration Within the Tumor MicroenvironmentSarah E Church, Jérôme Galon
Biomedicines|November 28, 2018
Dissecting the Immune Landscape of Acute Myeloid LeukemiaJan Davidson-Moncada, Elena Viboch, Sarah E Church, et al.
Frontiers in Immunology|May 16, 2022
Editorial: Mechanisms of Lymphocyte Exclusion in the Tumor MicroenvironmentRieneke van de Ven, Carlo B Bifulco, Jason J Luke, et al.
European Journal of Immunology|October 12, 2013
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cellsSarah E Church, Shawn M Jensen, Paul A Antony, et al.
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Multiple vaccinations: friend or foeSarah E Church, Shawn M Jensen, Christopher G Twitty, et al.
Breast Cancer Research : BCR|September 29, 2023
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trialChristine Lundgren, Julia Tutzauer, Sarah E Church, et al.
NPJ Breast Cancer|May 9, 2022
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patientsChristine Lundgren, Pär-Ola Bendahl, Sarah E Church, et al.
Cancers|August 26, 2022
Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal CancersElena Bolzacchini, Laura Libera, Sarah E Church, et al.
Journal of Translational Medicine|November 28, 2021
The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profilingIlana Schlam, Sarah E Church, Tyler D Hether, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Immunity|October 22, 2015
Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a GlimpseSarah E Church, Jérôme Galon
Advances in Experimental Medicine and Biology|December 25, 2017
Regulation of CTL Infiltration Within the Tumor MicroenvironmentSarah E Church, Jérôme Galon
Biomedicines|November 28, 2018
Dissecting the Immune Landscape of Acute Myeloid LeukemiaJan Davidson-Moncada, Elena Viboch, Sarah E Church, et al.
Frontiers in Immunology|May 16, 2022
Editorial: Mechanisms of Lymphocyte Exclusion in the Tumor MicroenvironmentRieneke van de Ven, Carlo B Bifulco, Jason J Luke, et al.
European Journal of Immunology|October 12, 2013
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cellsSarah E Church, Shawn M Jensen, Paul A Antony, et al.
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Multiple vaccinations: friend or foeSarah E Church, Shawn M Jensen, Christopher G Twitty, et al.
Breast Cancer Research : BCR|September 29, 2023
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trialChristine Lundgren, Julia Tutzauer, Sarah E Church, et al.
NPJ Breast Cancer|May 9, 2022
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patientsChristine Lundgren, Pär-Ola Bendahl, Sarah E Church, et al.
Cancers|August 26, 2022
Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal CancersElena Bolzacchini, Laura Libera, Sarah E Church, et al.
Journal of Translational Medicine|November 28, 2021
The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profilingIlana Schlam, Sarah E Church, Tyler D Hether, et al.
Pageof 4